Seeing Is Believing
Currently out of the existing stock ratings of Mara Goldstein, 130 are a BUY (75.58%), 40 are a HOLD (23.26%), 2 are a SELL (1.16%).
Analyst Mara Goldstein works at MIZUHO with a stock forecast success ratio of 42.46% fulfilled within 229.28 days on average.
Mara Goldstein’s has documented 320 price targets and ratings displayed on 33 stocks. The coverage is on Healthcare, Communication Services sectors.
Most recent stock forecast was given on RCUS, Arcus Biosciences at 30-Jan-2024.
Analyst best performing recommendations are on FTSV (FORTY SEVEN).
The best stock recommendation documented was for CRVS (CORVUS PHARMACEUTICALS) at 3/30/2023. The price target of $3.5 was fulfilled within 69 days with a profit of $2.71 (343.04%) receiving and performance score of 49.72.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
101
$-7.24 (-6.69%)
101
4 years 5 months 18 days ago
2/8 (25%)
$-7.53 (-6.94%)
171
Hold
115
$6.76 (6.25%)
102
4 years 5 months 18 days ago
3/12 (25%)
$6.47 (5.96%)
382
Hold
100
$-8.24 (-7.61%)
128
4 years 8 months ago
3/6 (50%)
$4.78 (5.02%)
159
Buy
102
$-6.24 (-5.76%)
105
4 years 11 months 16 days ago
3/3 (100%)
$5.12 (5.28%)
270
Hold
100
$-8.24 (-7.61%)
100
5 years 14 days ago
2/7 (28.57%)
$5.2 (5.49%)
282
Which stock is Mara Goldstein is most bullish on?
Which stock is Mara Goldstein is most reserved on?
What Year was the first public recommendation made by Mara Goldstein?